- Home
- TEVA vs Q Comparison
TEVA vs Q Comparison
Compare TEVA & Q Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEVA | Q |
|---|---|---|
| Founded | 1901 | 2024 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5B | 33.7B |
| IPO Year | 1996 | 2025 |
Fundamental Metrics
Financial Performance| Metric | TEVA | Q |
|---|---|---|
| Price | $36.61 | $141.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $38.63 | ★ $119.80 |
| AVG Volume (30 Days) | ★ 5.5M | 1.6M |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | ★ 183.45 | N/A |
| EPS | N/A | ★ 1.31 |
| Revenue | N/A | ★ $4,754,000,000.00 |
| Revenue This Year | N/A | $9.87 |
| Revenue Next Year | $2.97 | $7.64 |
| P/E Ratio | ★ N/A | $108.83 |
| Revenue Growth | N/A | ★ 9.67 |
| 52 Week Low | $17.33 | $72.81 |
| 52 Week High | $37.39 | $177.28 |
Technical Indicators
Market Signals| Indicator | TEVA | Q |
|---|---|---|
| Relative Strength Index (RSI) | 66.67 | 53.47 |
| Support Level | $30.42 | $137.15 |
| Resistance Level | $37.17 | $144.45 |
| Average True Range (ATR) | 1.04 | 5.88 |
| MACD | 0.34 | 1.70 |
| Stochastic Oscillator | 88.48 | 81.57 |
Price Performance
Historical ComparisonAbout TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About Q Qnity Electronics Inc.
Qnity is a specialty chemicals company created in 2025 after being spun off from DuPont. It sells chemicals and materials to the semiconductor industry, which generates the majority of sales, and also the electronics industry. Qnity specializes in materials science, including supplying key materials required to manufacture semiconductors and interconnected devices.